Do not use GLP-1 medications if you or any family member has a history of: Medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Seek immediate medical attention if you experience: A lump or swelling in your neck, trouble swallowing, hoarseness, or shortness of breath Severe abdominal pain that does not go away (possible pancreatitis) Signs of allergic reaction including swelling of face, lips, tongue, or throat Symptoms of low blood sugar (dizziness, confusion, rapid heartbeat, sweating) Changes in vision (particularly if you have diabetic retinopathy) Pain in upper stomach, fever, or yellowing of skin or eyes (possible gallbladder issues) Dosing Accuracy Matters With Compounded Vials FDA has warned about dosing errors with compounded injectable semaglutide, including cases where patients or clinicians miscalculated dose conversions (for example, milligrams to units or milliliters)

Other GLP-1 agonists being named in gastroparesis claims include: Wegovy (semaglutide) Mounjaro (tirzepatide) Rybelsus (semaglutide tablets) Saxenda (liraglutide) Trulicity (dulaglutide) Zepbound (tirzepatide) If you were diagnosed with NAION or gastroparesis after using Ozempic or another GLP-1 drug, you may qualify for a lawsuit
The compound's half-life is long enough that you'll maintain plasma levels, but the gastric effect peaks and wanes in a predictable curve
Buy MT-2 10mg in the UK from Imperial Peptides UK
After a single point liquid injection is completed, the hand holding the must remain absolutely still at the original angle and depth for 3 to 5 seconds